期刊文献+

尿α_1-微球蛋白和β_2-微球蛋白测定对汞作业者肾脏损害的早期诊断价值 被引量:5

Significance of Determination of Urinary α_1-microglobulin and β_2-microglobulin for Early Diagnosis of Renal Damage in Mercury Workers
下载PDF
导出
摘要 目的探讨尿α1-微球蛋白和β2-微球蛋白测定对汞作业者肾脏损害的早期诊断价值。方法85名汞作业者分为汞接触正常组、汞接触超标组,并以无汞接触史的65名健康成人作为对照组。分别进行临床体检并测定尿汞(UHg)、血肌酐(BCr)、尿肌酐(UCr)、血尿素氮(BUn)、尿α1-微球蛋白(α1-MG)和尿β2-微球蛋白(β2-MG),排除肾病史和患有肾脏疾病患者后对结果进行分析。结果汞作业者UHg为0.0145mg/L、α1-MG为0.48mg/mmolCr、β2-MG为5.48μg/mmolCr,均高于对照组,差异有统计学意义,BCr、UCr、BUn汞作业者与对照组差异无统计学意义。结论长期汞接触可造成肾功能损害,尿β2-MG和α1-MG可作为汞作业工人肾脏损害的早期敏感的诊断指标。 Objective To study the significance of determination of urinary α1-micrOglObulin and β2-microglobulin for early diagnosis of renal damage in mercury workers . Methods Eighty - five mercury workers were divided into 2 experimental groups: one with value and another with the urinary mercury level lower than the urinary mercury level higher than the normal the normal value. Sixty-five healthy adults without mercury exposure history were assigned to the control group. All the subjects had no renal disease history and did not suffer from renal diseases at that time. The results from the physical examinations and the measurements of UHg, BCr, UCr, BUN, urinary α1-microglobulin (α1-MG) and β2-microglobulin(β2-MG) in all the groups were analyzed Results The levels of UHg, urinary α1--microglobuhn and β2-microglobulin were significantly higher in the experimental groups than in the control group, however, the levels of BCr, UCr and BUN had no statistical difference between the experimental groups and the control group. Conclusion Exposure to mercury for a long time can cause renal damage. The level of urinary α1-microglobulin and β2-microglobulin can be used as sensitive indicators for detecting early renal damage caused by mercury.
出处 《预防医学情报杂志》 CAS 2007年第2期139-141,共3页 Journal of Preventive Medicine Information
基金 四川大学临床新技术基金资助课题(No.83504126002)
关键词 尿微蛋白 汞作业者 肾脏损害 早期诊断 Urinary microglobulin Mercury workers Renal damage Early diagnosis
  • 相关文献

参考文献12

二级参考文献11

  • 1刘卓宝,王培安,蒋志宏,扬文草,张兴苹,邵薇娟.汞接触者慢性肾损伤的早期指标研究[J].中国工业医学杂志,1993,6(3):143-145. 被引量:11
  • 2彭冬迪.α_1-微球蛋白与肾脏早期损害[J].临床荟萃,1997,12(3):97-98. 被引量:9
  • 3刘一兵 韩世泉 等.尿α1-微球蛋白放射免疫试剂盒的研制[J].同位素,1995,8(1):1-1.
  • 4黄芙蓉 王刚垛 等.亚急性汞中毒并发出血性结膜炎1例报告[J].职业医学,1993,20(3):159-159.
  • 5方国祥 张瑞芬 等.慢性汞中毒性肾病的发病调查[J].中华医学杂志,1982,62(10):595-595.
  • 6何凤生,中华职业医学,1999年,239页
  • 7Hostetther TH. DiabeticNephropathy. in: bremmer Bm, rector FC.The kidney, Vol, Ⅱ , 4th ed, philadephia SaundersWB, 1991; 1695
  • 8肖云,冯兆良,徐玉华,蔺心芳,宋笑年.汞作业工人肾损害的特点及其敏感指标[J]中华劳动卫生职业病杂志,1989(02).
  • 9赵金垣,王世俊.汞的慢性肾脏毒性研究的进展[J]国外医学(卫生学分册),1985(05).
  • 10郭卫星,王翔朴.尿酶与重金属中毒性肾损害[J]职业医学,1985(05).

共引文献208

同被引文献49

  • 1彭珊茁,张春生,胡元,张杰,魏明至,刘璐,王莹.职业接触汞工人肾脏早期损伤指标的探讨[J].中华劳动卫生职业病杂志,2004,22(2):122-124. 被引量:19
  • 2邓国栋,郑宝山,翟城,王建平,Ng Jack C..卟啉作为人体早期砷暴露生物标志的研究[J].环境科学,2007,28(5):1147-1152. 被引量:5
  • 3Ronco C, Chionh CY, Haapio M, et al. The cardiorenal syn- drome. Blood Purif,2009,27 : 114-126.
  • 4Kirklin JK, Naftel DC, Kormos RL, et al. Quantifying the effect of cardiorenal syndrome on mortality after left ventricular assist device implant. J Heart Lung Transplant,2013,32:1205-1213.
  • 5Larsen TR, Kinni V, Zaks J, et al. A lethal case of influenza and type 5 cardiorenal syndrome. Blood Purif, 2013,36: 112- 115.
  • 6Fabbian F, De Giorgi A, Pala M, et al. All-cause mortality in elderly adults diagnosed with cardiorenal syndrome after an inter- nal medicine unit admission. J Am Geriatr Soc,2013,61:2049- 2050.
  • 7Camuglia AC, Maeder MT, Starr J, et al. Impact of N-acetylcys- teine on endothelial function, B-type natriuretic peptide and renal function in patients with the cardiorenal syndrome: a pilot cross over randomised controlled trial. Heart Lung Circ ,2013,22:256- 259.
  • 8Leszek P, Kruszewski M. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type na- triuretic peptide levels in patients with cardiorenal anemia syn- drome. Am Heart J,2008,155 :e25, e19. C.
  • 9amuglia AC, Maeder MT, Starr J, et al. Impact of N-acetylcys- teine on endothelial function, B-type natfiuretic peptide and renal function in patients with the cardiorenal syndrome: a pilot cross over randomised controlled trial. Heart Lung Circ ,2013,22:256- 259.
  • 10Bart BA, Goldsmith SR, Lee KL, et aL Uhrafihration in decom- pensated heart failure with cardiorenal syndrome. N Engl J Med, 2012,367:2296-2304.

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部